Skip to content

Author

Wafaa S. Ramadan

We have 1 of 47 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Pharmacological inhibition of CBP sensitizes breast cancer to DNA-damaging agents by compromising DNA repair and cell cycle pathways.

In vitro and in vivo breast cancer models show that CBP inhibition disrupts DNA repair and cell-cycle regulatory pathways, thereby enhancing doxorubicin-induced cytotoxicity and apoptosis, and support a rational epigenetic-chemotherapy combination approach.

Wafaa S. Ramadan, Iman M. Talaat, A. Al-Azawi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.